Ecully, May 2nd, 2023 PCAS enters into exclusive negotiations with DIC Corporation following receipt of an offer for the acquisition of its Canadian subsidiary, PCAS Canada Inc. PCAS , specialized. | May 2, 2023
RELEASE OF THE 2022 UNIVERSAL REGISTRATION DOCUMENT Ecully, April 28, 2023 The PCAS Universal Registration Document 2022, which includes the annual financial report, was filed with France s. | April 28, 2023
Ecully, April 24, 2023 NET SALES AS OF MARCH 31, 2023 PCAS , a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication. | April 24, 2023
Ecully, March 30, 2023 2022 ANNUAL RESULTS PCAS , a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the. | March 30, 2023
RELEASE OF THE 2021 UNIVERSAL REGISTRATION DOCUMENT Ecully, April 29, 2022 The PCAS Universal Registration Document 2021, which includes the annual financial report, was filed with France s. | April 29, 2022